Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.51 -0.29 (-0.75%) Market Cap: 5.62 Bil Enterprise Value: 4.89 Bil PE Ratio: 0 PB Ratio: 18.97 GF Score: 70/100

From “The Gene” to Treatment: An Interactive Discussion with Ionis Pharmaceuticals Inc - Corporate Call Transcript

Apr 15, 2020 / 04:00PM GMT
Release Date Price: $50.81 (-3.71%)
Frank Rigo
Ionis Pharmaceuticals, Inc. - VP of Drug Discovery

Hi, everybody, welcome. Sorry for the technical challenge, but I think we're good now. Okay. So welcome, everyone. Thank you for joining this webcast. I am Frank Rigo, the Vice President of Functional Genomics and Drug Discovery at Ionis Pharmaceuticals, and I'm going to be the moderator today. I'm really excited to have a virtual discussion on some of the key science that was showcased in the documentary that was released recently by PBS called The Gene: An Intimate History.

The Gene is actually a 2-part documentary which is a beautiful journey of the history of the gene, intertwined with the stories of patients and families that are afflicted by terrible genetic diseases. The documentary also highlights in a very touching way the hope that is brought to patients in the form of new transformative medicines that come from understanding the very thing that unites us across the globe, which is our genes. So many of you are probably not aware that 3 of the stories of hope, the spinal muscular atrophy story, the Huntington's disease story

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot